FGF23 and the parathyroid glands

Pediatric Nephrology

Volumn 25, Issue 11, 2010, Pages 2241-2245

  Silver, Justin ^a   Naveh Many, Tally ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Calcium; FGF23; Klotho; Phosphate; PTH

Indexed keywords

CALCIDIOL 1 MONOOXYGENASE; CALCIMIMETIC AGENT; CALCITRIOL; CALCIUM; CYTOCHROME P450; CYTOCHROME P450 27B1; FIBROBLAST GROWTH FACTOR 23; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 1 C SPLICING FORM; KLOTHO PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PARATHYROID HORMONE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

CALCIUM BLOOD LEVEL; CHOROID PLEXUS; CHRONIC KIDNEY DISEASE; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GLOMERULUS FILTRATION RATE; HORMONE SYNTHESIS; HUMAN; HYPERPHOSPHATEMIA; KIDNEY DISTAL TUBULE; KIDNEY FAILURE; LOW DRUG DOSE; OSTEOBLAST; OSTEOCYTE; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HORMONE RELEASE; PARATHYROIDECTOMY; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; REVIEW; SECONDARY HYPERPARATHYROIDISM; SINUS NODE; TISSUE DISTRIBUTION; VITAMIN BLOOD LEVEL;

FIBROBLAST GROWTH FACTORS; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; PARATHYROID GLANDS; PARATHYROID HORMONE; PHOSPHATES; PHOSPHORUS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1;

EID: 77957260363     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-010-1565-3     Document Type: Review

References (36)

1. JQ Feng LM Ward S Liu Y Lu Y Xie B Yuan X Yu F Rauch SI Davis S Zhang H Rios MK Drezner LD Quarles LF Bonewald KE White 2006 Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism Nat Genet 38 1310 1315 1:CAS:528:DC%2BD28XhtFeisbjE 10.1038/ng1905 17033621 (Pubitemid 44646294)
2. RC Pereira H Juppner CE Azucena-Serrano O Yadin IB Salusky K Wesseling-Perry 2009 Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease Bone 45 1161 1168 1:CAS:528:DC%2BD1MXhtlGit7fE 10.1016/j.bone.2009.08.008 19679205
3. JQ Feng L Ye S Schiavi 2009 Do osteocytes contribute to phosphate homeostasis? Curr Opin Nephrol Hypertens 18 285 291 1:CAS:528: DC%2BD1MXnsFyhsbk%3D 10.1097/MNH.0b013e32832c224f 19448536
4. T Shimada T Muto I Urakawa T Yoneya Y Yamazaki K Okawa Y Takeuchi T Fujita S Fukumoto T Yamashita 2002 Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo Endocrinology 143 3179 3182 1:CAS:528: DC%2BD38Xls1Sgtbs%3D 10.1210/en.143.8.3179 12130585 (Pubitemid 34809892)
5. KE White WE Evans JLH O'Riordan MC Speer MJ Econs B Lorenz-Depiereux M Grabowski T Meitinger TM Strom 2000 Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 Nat Genet 26 345 348 1:CAS:528: DC%2BD3cXotVWhsbk%3D 10.1038/81664
6. LD Quarles 2008 Endocrine functions of bone in mineral metabolism regulation J Clin Invest 118 3820 3828 1:CAS:528:DC%2BD1cXhsVKgu73M 10.1172/JCI36479 19033649
7. T Shimada I Urakawa T Isakova Y Yamazaki M Epstein K Wesseling-Perry M Wolf IB Salusky H Juppner 2010 Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active J Clin Endocrinol Metab 95 578 585 1:CAS:528: DC%2BC3cXitVaisro%3D 10.1210/jc.2009-1603 19965919
8. OM Gutierrez M Mannstadt T Isakova JA Rauh-Hain H Tamez A Shah K Smith H Lee R Thadhani H Juppner M Wolf 2008 Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis N Engl J Med 359 584 592 1:CAS:528:DC%2BD1cXpt12qtro%3D 10.1056/NEJMoa0706130 18687639
9. G Jean JC Terrat T Vanel JM Hurot C Lorriaux B Mayor C Chazot 2009 High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients Nephrol Dial Transplant 24 2792 2796 1:CAS:528:DC%2BD1MXhtVGqu7rL 10.1093/ndt/gfp191 19395730
10. H Kurosu Y Ogawa M Miyoshi M Yamamoto A Nandi KP Rosenblatt MG Baum S Schiavi MC Hu OW Moe M Kuro-o 2006 Regulation of fibroblast growth factor-23 signaling by klotho J Biol Chem 281 6120 6123 1:CAS:528:DC%2BD28XhvFOhtLk%3D 10.1074/jbc.C500457200 16436388 (Pubitemid 43847540)
11. MS Razzaque D Sitara T Taguchi R St Arnaud B Lanske 2006 Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process FASEB J 20 720 722 1:CAS:528:DC%2BD28XjtlGqsb8%3D 16436465 (Pubitemid 46671193)
12. EG Farrow SI Davis LJ Summers KE White 2009 Initial FGF23-mediated signaling occurs in the distal convoluted tubule J Am Soc Nephrol 20 955 960 1:CAS:528:DC%2BD1MXlvFKqsbY%3D 10.1681/ASN.2008070783 19357251
13. K Takeshita T Fujimori Y Kurotaki H Honjo H Tsujikawa K Yasui JK Lee K Kamiya K Kitaichi K Yamamoto M Ito T Kondo S Iino Y Inden M Hirai T Murohara I Kodama Y Nabeshima 2004 Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression Circulation 109 1776 1782 10.1161/01.CIR.0000124224.48962.32 15037532 (Pubitemid 38500681)
14. A Imura A Iwano O Tohyama Y Tsuji K Nozaki N Hashimoto T Fujimori Y Nabeshima 2004 Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane FEBS Lett 565 143 147 1:CAS:528:DC%2BD2cXjvVGrs7o%3D 10.1016/j.febslet.2004.03.090 15135068 (Pubitemid 38595335)
15. S Fukumoto T Yamashita 2002 Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be phosphatonin Curr Opin Nephrol Hypertens 11 385 389 10.1097/00041552-200207000-00003 12105387 (Pubitemid 34734616)
16. RT Alexander TE Woudenberg-Vrenken J Buurman H Dijkman BC van der Eerden JP van Leeuwen RJ Bindels JG Hoenderop 2009 Klotho prevents renal calcium loss J Am Soc Nephrol 20 2371 2379 1:CAS:528:DC%2BD1MXhsFenur3P 10.1681/ASN.2008121273 19713312
17. T Isakova O Gutierrez A Shah L Castaldo J Holmes H Lee M Wolf 2008 Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD J Am Soc Nephrol 19 615 623 1:CAS:528:DC%2BD1cXktVamt7s%3D 10.1681/ASN.2007060673 18216315 (Pubitemid 351355405)
18. O Gutierrez T Isakova E Rhee A Shah J Holmes G Collerone H Juppner M Wolf 2005 Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease J Am Soc Nephrol 16 2205 2215 1:CAS:528:DC%2BD2MXms1egsLs%3D 10.1681/ASN.2005010052 15917335 (Pubitemid 41716454)
19. JH Ix MG Shlipak CL Wassel MA Whooley 2010 Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study Nephrol Dial Transplant 25 993 997 1:CAS:528:DC%2BC3cXislajtr8%3D 10.1093/ndt/gfp699 20037168
20. MA Mirza T Hansen L Johansson H Ahlstrom A Larsson L Lind TE Larsson 2009 Relationship between circulating FGF23 and total body atherosclerosis in the community Nephrol Dial Transplant 24 3125 3131 1:CAS:528:DC%2BD1MXhtFygsL3O 10.1093/ndt/gfp205 19429932
21. IZ Ben Dov H Galitzer V Lavi-Moshayoff R Goetz M Kuro-o M Mohammadi R Sirkis T Naveh-Many J Silver 2007 The parathyroid is a target organ for FGF23 in rats J Clin Invest 117 4003 4008 1:CAS:528:DC%2BD2sXhsValsLzL 17992255 (Pubitemid 350224109)
22. T Yamashita M Konishi A Miyake K Inui N Itoh 2002 Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway J Biol Chem 277 28265 28270 1:CAS:528:DC%2BD38XlvFKgu7Y%3D 10.1074/jbc.M202527200 12032146 (Pubitemid 34966781)
23. T Krajisnik P Bjorklund R Marsell O Ljunggren G Akerstrom KB Jonsson G Westin TE Larsson 2007 Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells J Endocrinol 195 125 131 1:CAS:528:DC%2BD2sXhtlWiu77P 10.1677/JOE-07-0267 17911404 (Pubitemid 350056006)
24. V Lavi-Moshayoff J Silver T Naveh-Many 2009 Human PTH gene regulation in vivo using transgenic mice Am J Physiol Renal Physiol 297 F713 F719 1:CAS:528:DC%2BD1MXhtFGrur%2FI 10.1152/ajprenal.00161.2009 19570881
25. Y Yamazaki T Tamada N Kasai I Urakawa Y Aono H Hasegawa T Fujita R Kuroki T Yamashita S Fukumoto T Shimada 2008 Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23 J Bone Miner Res 23 1509 1518 1:CAS:528:DC%2BD1cXhtFSlurjM 10.1359/jbmr.080417 18442315
26. H Galitzer IZ Ben-Dov J Silver T Naveh-Many 2010 Resistance of the parathyroid to FGF23 in secondary hyperparathyroidism of chronic kidney disease Kidney Int 77 211 218 1:CAS:528:DC%2BC3cXntVentg%3D%3D 10.1038/ki.2009.464 20016468
27. H Komaba S Goto H Fujii Y Hamada A Kobayashi K Shibuya Y Tominaga N Otsuki KI Nibu K Nakagawa N Tsugawa T Okano R Kitazawa M Fukagawa 2010 Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients Kidney Int 77 232 238 1:CAS:528:DC%2BC3cXntVemtQ%3D%3D 10.1038/ki.2009.414 19890272
28. H Komaba M Fukagawa 2009 FGF23-parathyroid interaction: implications in chronic kidney disease Kidney Int 77 292 298 10.1038/ki.2009.466 20010546
29. C Kumata M Mizobuchi H Ogata F Koiwa A Nakazawa F Kondo Y Kadokura E Kinugasa T Akizawa 2010 Involvement of Alpha-Klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism Am J Nephrol 31 230 238 1:CAS:528:DC%2BC3cXjtlait70%3D 10.1159/000274483 20068287
30. MH Lafage-Proust 2010 Does the downregulation of the FGF23 signaling pathway in hyperplastic parathyroid glands contribute to refractory secondary hyperparathyroidism in CKD patients? Kidney Int 77 390 392 1:CAS:528: DC%2BC3cXhvFGjtbY%3D 10.1038/ki.2009.512 20150940
31. S Liu W Tang J Zhou JR Stubbs Q Luo M Pi LD Quarles 2006 Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D J Am Soc Nephrol 17 1305 1315 1:CAS:528:DC%2BD28XkvVKrs7w%3D 10.1681/ASN.2005111185 16597685 (Pubitemid 43673410)
32. H Nishi T Nii-Kono S Nakanishi Y Yamazaki T Yamashita S Fukumoto K Ikeda A Fujimori M Fukagawa 2005 Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism Nephron Clin Pract 101 c94 c99 1:CAS:528:DC%2BD2MXpsFWjtLs%3D 10.1159/000086347 15956805 (Pubitemid 41208897)
33. JB Wetmore S Liu R Krebill R Menard LD Quarles 2010 Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD Clin J Am Soc Nephrol 5 110 116 1:CAS:528:DC%2BC3cXitVKksLg%3D 10.2215/CJN.03630509 19965548
34. T Kawata Y Imanishi K Kobayashi T Miki A Arnold M Inaba Y Nishizawa 2007 Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism J Am Soc Nephrol 18 2683 2688 1:CAS:528: DC%2BD2sXht1Krs7jJ 10.1681/ASN.2006070783 17855636 (Pubitemid 47531195)
35. WW Brown H Juppner CB Langman H Price EG Farrow KE White KL McCormick 2009 Hypophosphatemia with elevations in serum FGF23 in a child with Jansen's metaphyseal chondrodysplasia J Clin Endocrinol Metab 94 17 20 1:CAS:528:DC%2BD1MXptVKmsw%3D%3D 10.1210/jc.2008-0220 18854401
36. T Shimada Y Yamazaki M Takahashi H Hasegawa I Urakawa T Oshima K Ono M Kakitani K Tomizuka T Fujita S Fukumoto T Yamashita 2005 Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism Am J Physiol Renal Physiol 289 F1088 F1095 1:CAS:528: DC%2BD2MXht1CntLnP 10.1152/ajprenal.00474.2004 15998839 (Pubitemid 41447065)